AMA Calls for Stricter Botanical Drug Standards, Special Research Schedule
The AMA is calling for strict FDA standards on botanical drugs including cannabis and kratom while proposing a special research schedule to ...
Tag
#FDA
Industry News
Oregon Hemp Retailers Warn Federal Rules Could Shut Down CBD Market
Oregon hemp retailers warn that pending federal regulatory changes will shut down CBD businesses, eliminating consumer access to popular pet...
Legislation
DEA Pushes Psychedelic Bans While FDA Opens Therapeutic Pathways
The DEA is moving to ban several psychedelics as Schedule I substances while the FDA holds hearings on accelerating therapeutic access, crea...
Legislation
Federal Health Agency Urges States to Prepare for Psychedelic Drug Approval
A federal health agency published guidance urging states to prepare regulatory frameworks for psychedelic therapies ahead of expected FDA ap...
Medical Cannabis
German Regulators Approve Cannabis Extract Exilby for Chronic Pain
Germany has authorized Exilby, a whole-plant cannabis extract, for chronic pain treatment, while the FDA granted it breakthrough therapy sta...
Medical Cannabis
FDA Grants Breakthrough Status to German Cannabis Pain Drug
The FDA granted Breakthrough Therapy Designation to Vertanical's VER-01, a full-spectrum cannabis drug for chronic low back pain, following ...
Legislation
FDA Signals Hemp CBD Enforcement Shift, But Industry Wants Legislation
The FDA's new hemp CBD enforcement guidance offers temporary relief to the industry, but stakeholders say only comprehensive congressional l...
Legislation
Connecticut Expands Psychedelics Pilot as FDA Decision Looms
Connecticut's Joint Committee on Public Health advanced legislation expanding the state's psychedelic therapy pilot program to include first...
Legislation
Alaska Task Force Backs Psychedelic Therapy Framework Tied to FDA Action
Alaska's psychedelics task force recommends establishing a regulated therapy framework for psilocybin and MDMA, contingent on FDA approval. ...
Legislation
Bipartisan Hemp Bill Offers Regulatory Path After Trump Ban
House lawmakers introduced bipartisan legislation to regulate consumable hemp products through FDA oversight, offering an alternative to the...
Legislation
New Bill Would Give FDA Authority Over Hemp, Enable CBD Medicare
Bipartisan legislation would grant FDA authority over hemp-derived CBD for the first time and create a pathway for Medicare coverage, fulfil...